US Patent 8058304 Merged ion channel modulating compounds and uses thereof
Patent 8058304 was granted and assigned to Cardiome Pharma on November, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+327 characters)
Article
Patent abstract
Merged compounds of ion channel modulating compounds, including, for example, merged compounds of the ion channel modulating compound of the following formula: (I) are described herein, as well as methods of making and using such merged compounds and pharmaceutical compositions containing such merged compounds.
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Bertrand M. C. Plouvier0
Doug Ta Hung Chou0
Grace Jung0
Lewis S. L. Choi0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08058304 Merged ion channel modulating compounds and uses thereof US Patent 8058304 Merged ion channel modulating compounds and uses thereof
Infobox
Patent Number
080583040
Patent Number
80583040
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080583040
Date of Patent
November 15, 2011
0Patent Application Number
115474220
Date Filed
April 1, 2005
0Patent Primary Examiner
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08058304 Merged ion channel modulating compounds and uses thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08058304
Date of patent
November 15, 2011
Patent application number
11547422
Date Filed
April 1, 2005
Patent primary examiner
Find more entities like US Patent 8058304 Merged ion channel modulating compounds and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.